Stevanato Group stock dividend – Stevanato Group Announces Change in Ex-Dividend Date for its Dividend

June 26, 2023

🌥️Trending News

Stevanato Group ($NYSE:STVN) S.p.A., a global leader in drug containment and drug delivery, announced today that the ex-dividend date for its dividend has been changed. This announcement was made from the company’s headquarters in Piombino Dese, Italy, on June 07, 2023. Stevanato Group is a publicly traded Italian company that specializes in the production of pharmaceutical glass containers and medical devices. It is listed on the Milan Stock Exchange and is one of the largest players in the European market for these products. The company has established an excellent track record of dividend payments over the last several years, and this announcement reaffirms its commitment to shareholders.

The news of Stevanato Group’s change in ex-dividend date for its dividend was welcomed by investors, with shares of the company rising by almost 2% on the Milan Stock Exchange following the announcement. This indicates that investors have confidence in the company and are trusting it to deliver on its financial commitments. Overall, the announcement that Stevanato Group has changed its ex-dividend date for its dividend is good news for investors who have been looking for a reliable source of income from their investments. The company’s commitment to its shareholders is clearly demonstrated, and investors can be sure that they will receive their dividends in a timely manner.

Dividends – Stevanato Group stock dividend

Over the last two years, the Group has issued an annual dividend per share of 0.05 EUR. Based on dividend yields from 2022 to 2023, the average dividend yield is 0.34%. The new ex-dividend date has been set to a date to be determined, and these changes will become effective on the new ex-dividend date. Upon the effective date, the Group’s shareholders of record as of the new ex-dividend date will be eligible to receive the dividend payment.

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Stevanato Group. More…

    Total Revenues Net Income Net Margin
    1.01k 143.39 14.5%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Stevanato Group. More…

    Operations Investing Financing
    135.3 -317.1 -25.64
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Stevanato Group. More…

    Total Assets Total Liabilities Book Value Per Share
    1.74k 712.64 3.89
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Stevanato Group are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    22.4% 45.7% 19.0%
    FCF Margin ROE ROA
    -18.0% 11.8% 6.9%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Market Price

    Following the announcement, the company’s share price opened at $28.1 and closed at $29.0, indicating a 4.3% increase from its previous closing price of $27.8. This marks the second consecutive day that STEVANATO’s stock has gone up, further indicating that the company is taking measures to improve its performance and profitability. Investors will now need to own the stock by the new ex-dividend date in order to be eligible for any dividends payable on the stock. Live Quote…

    Analysis

    At GoodWhale, we conducted an in-depth analysis of STEVANATO GROUP’s fundamentals to determine its risk rating. After our examination, we determined that the company is a medium risk investment when it comes to financial and business aspects. Additionally, our analysis revealed two areas of concern on the company’s balance sheet and cashflow statement. If you’re interested in learning more about these risk warnings and how they could affect your investment in STEVANATO GROUP, please register with us to get more details. We hope this assessment can help you make the best decisions for your investments. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    The company has a long history of success and has a strong market presence in Europe, North America, and Asia. Its main competitors are One Glove Group Bhd, Essilorluxottica, and Ansell Ltd.

    – One Glove Group Bhd ($KLSE:5079)

    One Glove Group Bhd is a Malaysian company that manufactures and sells gloves. The company has a market capitalization of 133.48 million as of 2022 and a return on equity of -17.63%. One Glove Group Bhd is involved in the production of latex, nitrile, and vinyl gloves. The company also provides gloves for the food, healthcare, and industrial sectors.

    – Essilorluxottica ($OTCPK:ESLOY)

    With a market capitalization of 78.25 billion as of 2022 and a return on equity of 4.79%, EssilorLuxottica is a French-Italian multinational corporation that designs, manufactures, and markets ophthalmic lenses, optical frames, sunglasses, contact lenses, and prescription eyewear. The company also provides eye care services. EssilorLuxottica is headquartered in Paris, France.

    – Ansell Ltd ($ASX:ANN)

    Ansell Ltd is a publicly traded company with a market capitalization of 3.53 billion as of 2022. The company has a return on equity of 9.21%. Ansell is a global leader in providing protective solutions. The company designs, develops, manufactures, and markets a variety of protection solutions, including gloves, clothing, and other products.

    Summary

    Stevanato Group S.p.A. recently announced a change in their ex-dividend date for their dividend, causing the stock price to move up on the same day. Investing in Stevanato Group could be a beneficial opportunity for those looking for long-term investment options. The company is a leading global provider of drug containment, drug delivery, and drug device solutions, making them a key player in the health care industry.

    Additionally, their strong financial performance and consistent dividend payments make them an attractive option for investors. Moreover, their history of innovation and development of new products puts them at the forefront of the industry. Thus, Stevanato Group is a reliable company that could be a viable investment choice for those looking for long-term growth.

    Recent Posts

    Leave a Comment